BioCentury
ARTICLE | Clinical News

Oral omecamtiv mecarbil: Completed Phase II enrollment

March 23, 2015 7:00 AM UTC

Cytokinetics and Amgen completed enrollment of about 450 patients in the dose-expansion portion of the double-blind, placebo-controlled, international Phase II COSMIC-HF trial evaluating 25 or 50 mg o...